Youssef S, Hachem R, Chemaly J, Adachi J, Jacobson K, Jiang Y, Rolston K, Safdar A, Kontoyiannis D, Raad I. Vitamin B6 was not effective for the prevention of hematologic toxicities of linezolid in cancer patients. Abstract # 169. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada. February 2, 2018/in Research Presentations/by Amar Safdar
Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly R, Raad I. Comparative analysis of vancomycin resistant Enterococcus faecalis vs. VRE faecium in cancer patients. Abstract # 443. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada. February 2, 2018/in Research Presentations/by Amar Safdar
Torres HA, Aguilera E, Rohatgi N, Raad II, Sepulveda C, Safdar A, Knotoyiannis DP, Chemaly RF. Cytomegalovirus pneumonia in patients with hematologic malignancies: an autopsy-based case-control study. Abstract # 787. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada. February 2, 2018/in Research Presentations/by Amar Safdar
Chemaly RF, Hachem R, Hanmod S, Adachi J, Kontoyiannis D, Safdar A, Raad II, Rolston KVI. Clinical experience with tigecycline in cancer patients: a report on 28 cases. Abstract # 1719. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada. February 2, 2018/in Research Presentations/by Amar Safdar
Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II. Scedosporium in a tertiary care cancer center in the past 16 years. Abstract # 554. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez G, Balakrishnan M, Tarrand J, Rolston KVI. Changing trends of bacteremia in patients with cancer. Analysis of 2,080 quantitative blood cultures during 1998 and 2004. Abstract # 94. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez G, Rolston KVI, Kantarjian HM, Bodey GP, Champlin RE, Knotoyiannis D, Raad II. Efficacy of high-dose (100mg) caspofungin combination antifungal therapy in cancer patients with invasive fungal infections: case-controlled observational analysis during 2002-2004. Abstract # 93. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez A, Luis FE, Romaguera JE, Hagemeister FB, McLauglin PW, Kwak L, Couch RB. A trial of increasing dose of baculovirus-expressed trivalent influenza HA vaccine: prospective, randomized, double blind study in adult patients with B-cell non-Hodgkin’s lymphoma. Abstract # 92. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez G, Lichtiger B, Champlin R, Rreireich EJ, Kantarjian HM. Safety and efficacy of recombinant interferon-gamma-1b immune adjuvant in 20 patients receiving high-dose donor granulocyte transfusions–an observational study during 2000 – 2004. Abstract # 91. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez G, Delima M, et al. Infections complicating unrelated donor cordblood stem-cell transplantation: 281 episodes in recipients of 100 CBST at a comprehensive cancer center (1996-2005). Abstract # 42. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland. February 2, 2018/in Research Presentations/by Amar Safdar
